Superworth

PepGen EPS PEPG

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 30, 2026
−$1.31
Latest quarter, Q2 FY26
−$0.26
Fiscal year 2025
−$2.41

PepGen's earnings per share was −$1.31 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.26.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.41n/a
FY2024−$2.84n/a
FY2023−$3.31n/a
FY2022−$21.59n/a
FY2021−$30.27n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.26n/a−$1.31
Q1 FY26−$0.26n/a−$1.75
Q4 FY25−$0.27n/a−$2.41
Q3 FY25−$0.52n/a−$2.82
Q2 FY25−$0.70n/a−$2.96
Q1 FY25−$0.92n/a−$3.13
Q4 FY24−$0.68n/a−$2.84
Q3 FY24−$0.66n/a−$2.98
Q2 FY24−$0.87n/a−$3.30
Q1 FY24−$0.63n/a−$3.25
Q4 FY23−$0.82n/a−$3.31
Q3 FY23−$0.98n/a−$3.12

Against its peers

Companies in Drug Manufacturers - General nearest PepGen's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PEPGPepGen−$1.31
NATRNatures Sunshine Products$1.01+36% a year
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
ATNMActinium Pharmaceuticals$0.36
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on PepGen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.